Home/Filings/4/0001179110-19-001321
4//SEC Filing

Chondros Dimitrios 4

Accession 0001179110-19-001321

CIK 0001159036other

Filed

Feb 4, 7:00 PM ET

Accepted

Feb 5, 4:12 PM ET

Size

4.9 KB

Accession

0001179110-19-001321

Insider Transaction Report

Form 4
Period: 2019-02-03
Chondros Dimitrios
SVP, Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock

    2019-02-03$16.12/sh2,503$40,34831,599 total
Footnotes (1)
  • [F1]The reported disposition of 2,503 shares represents the shares that were withheld by the issuer as payment for minimum statutory obligations due upon vesting of 6,165 restricted stock award shares.

Issuer

HALOZYME THERAPEUTICS INC

CIK 0001159036

Entity typeother

Related Parties

1
  • filerCIK 0001739693

Filing Metadata

Form type
4
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 4:12 PM ET
Size
4.9 KB